agoniste glp 1 GLP-1 Receptor Agonist Market Size Current Insights, Advantages and Challenges
Description
Certain genetic variants, carried by around 10 percent of the population, could be making type 2 diabetes GLP-1 treatments (such as Ozempic and Wegovy) less effective, according to new research.
It raises the risk of type 2 diabetes, heart disease, sleep problems, and depression conditions that already shadow many people with ADHD
It operates by mimicking a hormone that regulates appetite, which can lead to []
The net effect is that after MBS, endogenous GLP-1 primarily acts on the brain to inhibit appetite, while only 10% of the secreted GLP-1 reaches the pancreas
these signals are hypothesis-generating and should not be interpreted as confirmed causal risks
